Veterinary drug maker Lasa Supergenerics acquires Harishree Aromatics Medical Dialogues Bureau28 Feb 2020 9:00 AM ISTThe amalgamation of both the entities stands to extract synergistic benefits, economies of scale, better cash flow management, optimisation of...
AstraZeneca to sublicense global rights to Movantik Medical Dialogues Bureau28 Feb 2020 9:00 AM ISTMovantik is a once-daily oral PAMORA approved by the US Food and Drug Administration for the treatment of OIC in adult patients with chronic...
Members are ready to brace up for any shortages in medical equipment: MTaI Medical Dialogues Bureau27 Feb 2020 5:48 PM ISTNew Delhi: Medical Technology Association of India (MTaI), which is an association of leading research-based medical technology companies today said...
Sun Pharma launches RIOMET ER diabetes drug in the US Medical Dialogues Bureau27 Feb 2020 4:30 PM ISTRiomet ER™, dosed once daily, is the first and only FDA-approved liquid formulation of extended-release metformin.
Sourav Ganguly becomes the brand Ambassador for Piramal's antacid Polycrol Medical Dialogues Bureau27 Feb 2020 2:02 PM ISTAvailable in a mint flavour, Polycrol is one of India's leading liquid antacid brands, and is amongst the top 3 in Eastern India, including West...
USFDA inspection at Cipla manufacturing facility in Goa, warning letter issued Medical Dialogues Bureau27 Feb 2020 1:56 PM ISTNew Delhi: Drug firm Cipla recently announced that it has received a warning letter from USFDA for its goa Manufacturing Facility.Pursuant to...
APEIRON to start a pilot clinical trial to treat coronavirus disease COVID-19 in China with APN01 Medical Dialogues Bureau27 Feb 2020 10:00 AM ISTVienna: APEIRON Biologics AG, a biotechnology company with an approved product on the market as well as a broad preclinical and clinical pipeline, has...
COVID-19 Treatment: WuXi Biologics, Vir Biotechnology collaborate for Global Development of antibodies Medical Dialogues Bureau27 Feb 2020 9:00 AM ISTWuXi Biologics will conduct cell-line development, process and formulation development, if the antibodies receive regulatory approvals, WuXi Biologics...
Sanofi plans to create standalone company dedicated to making APIs Medical Dialogues Bureau26 Feb 2020 3:37 PM ISTPARIS : Sanofi plans to create a standalone company dedicated to making active pharmaceutical ingredients (API), components that are biologically...
Lupin launches Ethacrynic Acid Tablets USP, 25 mg Medical Dialogues Bureau26 Feb 2020 3:27 PM ISTThe product would be manufactured at Lupin's Nagpur OSD facility, India.
Gilead's drug leads global race to find virus treatment Medical Dialogues Bureau26 Feb 2020 2:24 PM ISTBeijing | Tokyo: China will release results at the end of April from clinical trials of a Gilead Sciences drug that is emerging as a frontrunner in...
Beximco Pharma announces Commercial Agreement with Mylan in Bangladesh Medical Dialogues Bureau25 Feb 2020 4:28 PM ISTBeximco Pharmaceuticals Limited, manufacturer of generic pharmaceutical products and active pharmaceutical ingredients, has announced the signing of a...
